Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Proteomes|June 2, 2021
Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease BiomarkersShuvolina Mukherjee, Karin Sundfeldt, Carl A K Borrebaeck, et al.
The Journal of Molecular Diagnostics : JMD|January 19, 2025
Optimization of Pre-Analytical Handling to Maintain DNA Integrity in Diagnostic Papanicolaou TestsSara Schumacher, Jacob Malchau Lauesgaard, Therese Carlsson, et al.
BMC Psychiatry|March 22, 2024
Awareness of somatisation disorder among Swedish physicians at emergency departments: a cross-sectional surveyCarina Iloson, Marcus Praetorius Björk, Anna Möller, et al.
Gynecologic Oncology|June 13, 2020
Long-term survival in obese patients after robotic or open surgery for endometrial cancerAnna Lindfors, Heshoo Heshar, Claudia Adok, et al.
Clinical Chemistry and Laboratory Medicine|August 13, 2021
Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor diagnosticsMaria Lycke, Benjamin Ulfenborg, Jacob Malchau Lauesgaard, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 16, 2026
Somatization and experience of physical, psychological, and sexual violence among women consulting gynecological clinics: a waiting room surveyCarina Iloson, Susanne Bernhardsson, Marcus Praetorius Björk, et al.
Cancers|September 2, 2020
Preoperative Fasting and General Anaesthesia Alter the Plasma ProteomeUlf Gyllensten, Sofia Bosdotter Enroth, Karin Stålberg, et al.
International Urogynecology Journal|January 25, 2017
Patient-reported lower urinary tract symptoms after hysterectomy or hysteroscopy: a study from the Swedish Quality Register for Gynecological SurgeryMathias Pålsson, Jan-Henrik Stjerndahl, Gabriel Granåsen, et al.
The Lancet Regional Health. Europe|February 20, 2025
Salpingectomy versus tubal occlusion in laparoscopic sterilisation (SALSTER): a national register-based randomised non-inferiority trialAnnika Strandell, Leonidas Magarakis, Karin Sundfeldt, et al.
BMC Cancer|September 25, 2009
External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomasKarolina Partheen, Kristina Levan, Lovisa Osterberg, et al.
Pageof 10